表紙
市場調査レポート

動物用抗菌剤および抗生物質市場:製品別(テトラサイクリン、ペニシリン、スルホンアミド、アミノグリコシド)、動物別(犬、鶏、豚)、投与方法別(プレミクス、経口粉末および溶剤、注射剤)の世界市場予測

Animal Antimicrobials and Antibiotics Market by Products (Tetracyclines, Penicillins, Sulfonamides, Aminoglycosides), Animals (Dog, Poultry, Swine), Mode Of Delivery (Premixes, Oral Powders and Solutions, Injections) - Global Forecasts to 2018

発行 MarketsandMarkets 商品コード 301390
出版日 ページ情報 英文 295 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.85円で換算しております。
Back to Top
動物用抗菌剤および抗生物質市場:製品別(テトラサイクリン、ペニシリン、スルホンアミド、アミノグリコシド)、動物別(犬、鶏、豚)、投与方法別(プレミクス、経口粉末および溶剤、注射剤)の世界市場予測 Animal Antimicrobials and Antibiotics Market by Products (Tetracyclines, Penicillins, Sulfonamides, Aminoglycosides), Animals (Dog, Poultry, Swine), Mode Of Delivery (Premixes, Oral Powders and Solutions, Injections) - Global Forecasts to 2018
出版日: 2014年05月05日 ページ情報: 英文 295 Pages
概要

世界の動物用抗菌剤および抗生物質市場は2013年に33億4,080万米ドルとなり、2018年までに41億3,400万米ドルに達すると予測されています。新興市場における動物用タンパク質製品の需要の拡大やコンパニオンアニマルの所有数増大が市場の成長を牽引する要因となっています。また、中国やインドなどの新興市場では、好景気に加え、食事の欧米化によって動物用製品の需要が拡大し、同時に動物の疾病発症率も上昇しています。各企業はこうした地域に子会社を設立し、同地域での地盤固めに投資しています。

当レポートでは、動物用抗菌剤および抗生物質市場の概要とともに、製品別、動物別、投与方法別、地域別動向、および参入企業のプロファイルをまとめ、概略下記の構成で取り上げております。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 プレミアムインサイト

  • 動物用タンパク質製品の消費拡大が抗菌剤市場の大きな成長機会に
  • 一人あたりのコンパニオンアニマルの医療費増大が市場の成長を牽引
  • 法規制による未認可の抗生物質使用禁止が成長を阻害
  • アジア太平洋地域、中東、ラテンアメリカなどの新興市場の高い成長可能性

第4章 市場概要

  • イントロダクション
  • 市場セグメンテーション
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会
  • 市場シェア分析

第5章 製品別市場

  • イントロダクション
    • テトラサイクリン
    • ペニシリン
    • スルホンアミド
    • マクロライド
    • アミノグリコシド
    • セファロスポリン
    • その他

第6章 投与方法別市場

  • イントロダクション
    • プレミクス
    • 経口粉末・溶剤
    • 注射剤
    • 乳房内製剤
    • その他

第7章 動物別市場

  • イントロダクション
  • 食料生産動物
    • 羊・山羊
  • コンパニオンアニマル
  • その他

第8章 地域別分析

  • イントロダクション
    • 北米
    • 欧州
    • アジア太平洋地域
    • その他

第9章 競合環境

  • イントロダクション
  • 合併・買収
  • 新製品上市
  • 協定、連携、提携
  • 拡大
  • その他

第10章 企業プロファイル

  • Zoetis, Inc.
  • Merck And Co., Inc.
  • Bayer Ag
  • Virbac Sa
  • Eli Lilly And Company
  • Boehringer Ingelheim
  • Sanofi
  • Novartis Ag
  • Ceva Sante Animale
  • Vetoquinol

図表

目次
Product Code: PH 2458

Antimicrobials and antibiotics form a major share of the animal health market. Animal antimicrobials gained a greater importance in the animal health industry in the past 20 years, mainly due to growing need to preserve the health and welfare of animals. Most of the antimicrobial agents were also used as growth promoters as well. With this, the animal antimicrobials market witnessed a bullish growth from 1990's to 2006.

However, gradually, there were growing concerns about emergence of antibiotic-resistant bacteria which led to worldwide initiatives to minimize the use of antimicrobial agents as a growth promoter in food-producing animals. In Europe, in 2006, a complete ban was imposed on use of antimicrobial agents in food-producing animals, which brought a huge setback to the growing market for antimicrobial and antibiotics in Europe.

At present, the global antimicrobials and antibiotics market is driven by the growing need to preserve animal health owing to rising demand for animal proteins across the globe, and growing demand in the companion animals segment. Growing livestock population, increasing incidences of disease outbreaks and increase in the companion animal ownership are some of the factors driving the growth of this market to a certain extent. Besides the structural market drivers, there are strong geographic drivers for the growth of the animal antimicrobials and antibiotics market. The emerging markets are becoming increasingly attractive. The Asian and Latin American region form one of the most promising animal antimicrobials and antibiotics markets in the world. Developing countries such as China and India have a relatively high CAGR rate and are expected to witness significant market growth in the forecast period. The growth in these regions is mainly attributed to the rise in demand for animal protein products, along with an increase in the trend of companion animal ownership in these regions.

Today, the animal antimicrobials and antibiotics market showcase a sluggish growth, owing to the regulatory authorities restricting their use, increased usage of in-feed enzymes, competitive exclusion products and probiotics as an alternative to antibiotics and prophylactic use of antibiotics being replaced by good husbandry, environment and hygienic practices.

Tetracyclines dominated the animal antimicrobials and antibiotics product segment in 2013, accounting for around 60% of the market revenue. This was followed by others segment, which accounted for 16% of the global animal antimicrobials and antibiotics product market in 2013. In the global antimicrobials and antibiotics animal market, pigs dominated the market with a share of close to 25%. In the mode of delivery segment of animal antimicrobials and antibiotics market, premix was the major revenue contributor in 2013, with an estimated share of nearly 49%.

North America dominated the animal antimicrobials and antibiotics market in 2013. However, the market share of this region will decrease to 27%, primarily due to the regulatory ban on the use of antibiotics announced in the U.S. At the same time, Asia and Latin America are poised to grow at a CAGR of 6% to 8% in the forecast period; this growth is largely driven by the increased urbanization, rising disposable incomes, increase in the demand for animal products and the increasing trend of pet ownerships in these regions.

The global animal antimicrobials and antibiotics market is consolidated with Zoetis Inc. (U.S.), Elanco Animal Health (U.S.), Merck Animal Health (U.S.), Merial (U.S.), Bayer Animal Health (Germany) holding around 75% of the total market. Other major players in this market are Virbac Animal Health (U.S.), and CEVA Sante Animale (U.S.).

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering greater market shares. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the animal antimicrobials and antibiotics market. The report analyzes the animal antimicrobials and antibiotics market by animals type, mode of delivery type and by product type across all geographies.
  • Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the animal antimicrobials and antibiotics market.
  • Market Development: Comprehensive information about the lucrative emerging markets by product, functionality, and geography.
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the animal antimicrobials and antibiotics market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the animal antimicrobials and antibiotics market.

Table of Contents

1. Introduction

  • 1.1. Objectives Of The Study
  • 1.2. Report Description
  • 1.3. Markets Covered
  • 1.4. Stakeholders
  • 1.5. Research Methodology
    • 1.5.1. Market Size Estimation
    • 1.5.2. Market Crackdown And Data Triangulation
    • 1.5.3. Market Share Estimation
    • 1.5.4. Key Data From Secondary Sources
    • 1.5.5. Key Data Points From Primary Sources
    • 1.5.6. Assumptions

2. Executive Summary

3. Premium Insights

  • 3.1. Growing Consumption Of Animal Protein Products Provides Significant Growth Opportunities For Antimicrobials Market
  • 3.2. Growing Per Capita Companion Animal Heatlh Expenditure To Drive The Market Growth
  • 3.3. Regulatory Ban On Unauthorized Usage Of Antibiotics Curbing The Growth
  • 3.4. High-Growth Potential Of Emerging Markets In Asia-Pacific, Middle East, And Latin America

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Segmentation
  • 4.3. Market Dynamics
    • 4.3.1. Key Market Drivers
      • 4.3.1.1. Rising Demands For Livestock Products Due To Growing Livestock Population Worldwide
      • 4.3.1.2. Increasing Incidences Of Animal Disease Outbreaks Leading To High Utilization Of Antibiotics
      • 4.3.1.3. Increased Use Of Approved Antimicrobial Agents To Promote Growth And Feed Efficiency In Food Animals
      • 4.3.1.4. Growing Demand For Animal Antimicrobials In China
      • 4.3.1.5. Increase In The Companion Animal Ownership Across The World
    • 4.3.2. Key Market Restraints
      • 4.3.2.1. Regulatory Authorities Curbing The Growth Of Antimicrobials And Antibiotics Market
      • 4.3.2.2. Dearth Of New Antibiotics In The Market
      • 4.3.2.3. Routine Prophylactic Use Of Antibiotics Being Replaced By Good Husbandry, And Hygiene Practices
      • 4.3.2.4. Increased Use Of In-Feed Enzymes, Competitive Exclusion Products Or Probiotics As An Alternatives To Antibiotics
    • 4.3.3. Key Market Opportunities
      • 4.3.3.1. Growing Demand For Pet Animals In The Emerging Markets
      • 4.3.3.2. Rapid Growth In Pet Health Insurance Is Driving The Animal Antimicrobials And Antibiotics Market
  • 4.4. Global Market Share Analysis

5. Veterinary Antimicrobials And Antibiotics Market, By Product

  • 5.1. Introduction
    • 5.1.1. Tetracyclines
    • 5.1.2. Penicillins
    • 5.1.3. Sulfonamides
    • 5.1.4. Macrolides
    • 5.1.5. Aminoglycosides
    • 5.1.6. Cephalosporins
    • 5.1.7. Others

6. Veterinary Antimicrobials And Antibiotics Market, By Mode Of Delivery

  • 6.1. Introduction
    • 6.1.1. Premixes
    • 6.1.2. Oral Powders & Solutions
    • 6.1.3. Injections
    • 6.1.4. Intramammary Preparations
    • 6.1.5. Other Preparations

7. Veterinary Antimicrobials And Antibiotics Market, By Type Of Animal

  • 7.1. Introduction
  • 7.2. Food-Producing Animals
    • 7.2.1. Cattle
    • 7.2.2. Pigs
    • 7.2.3. Poultry
    • 7.2.4. Sheep And Goats
  • 7.3. Companion Animals
    • 7.3.1. Dogs
    • 7.3.2. Cats
    • 7.3.3. Horses
  • 7.4. Other Animals

8. Geographic Analysis

  • 8.1. Introduction
    • 8.1.1. North America
      • 8.1.1.1. U.S.
      • 8.1.1.2. Canada
    • 8.1.2. Europe
      • 8.1.2.1. U.K.
      • 8.1.2.2. Germany
      • 8.1.2.3. France
      • 8.1.2.4. Italy
      • 8.1.2.5. Spain
      • 8.1.2.6. Rest Of Europe
    • 8.1.3. Asia-Pacific
      • 8.1.3.1. Japan
      • 8.1.3.2. China
      • 8.1.3.3. India
      • 8.1.3.4. Rest Of Asia-Pacific
    • 8.1.4. Rest Of The World (Row)
      • 8.1.4.1. Latin America
      • 8.1.4.2. Middle East And Africa

9. Competitive Landscape

  • 9.1. Introduction
  • 9.2. Mergers And Acquisitions
  • 9.3. New Product Launches
  • 9.4. Agreements, Collaborations, And Partnerships
  • 9.5. Expansions
  • 9.6. Others

10. Company Profiles (Business Overview, Products, Financials, Growth Strategy, Recent Developments, Swot Analysis, & Mnm View)*

  • 10.1. Zoetis, Inc.
  • 10.2. Merck And Co., Inc.
  • 10.3. Bayer Ag
  • 10.4. Virbac Sa
  • 10.5. Eli Lilly And Company
  • 10.6. Boehringer Ingelheim
  • 10.7. Sanofi
  • 10.8. Novartis Ag
  • 10.9. Ceva Sante Animale
  • 10.10. Vetoquinol

*Details On Business Overview, Products, Financials, Growth Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

List of Tables

  • Table 1: Global Animal Antimicrobials And Antibiotics Market, By Product, 2011
  • -2018 ($Million)
  • Table 2: Global Tetracyclines Market, By Geography, 2011-2018 ($Million)
  • Table 3: Global Penicillins Market, By Geography, 2011-2018 ($Million)
  • Table 4: Global Sulfonamides Market, By Geography, 2011-2018 ($Million)
  • Table 5: Global Macrolides Market, By Geography, 2011-2018 ($Million)
  • Table 6: Global Aminoglycosides Market, By Geography, 2011-2018 ($Million)
  • Table 7: Global Cephalosporins Market, By Geography, 2011-2018 ($Million)
  • Table 8: Global Others Market, By Geography, 2011-2018 ($Million)
  • Table 9: Global Veterinary Antimicrobials And Antibiotics Market, By Mode Of Delivery, 2011-2018 ($Million)
  • Table 10: Global Premixes Market For Animal Antimicrobials And Antibiotics, By Geography, 2011-2018 ($Million)
  • Table 11: Global Oral Powders And Solutions Market For Animal Antimicrobials And Antibiotics, By Geography, 2011-2018 ($Million)
  • Table 12: Global Injections Market For Veterinary Antimicrobials And Antibiotics, By Geography, 2011-2018 ($Million)
  • Table 13: Global Intramammary Preparations Market For Animal Antimicrobials And Antibiotics, By Geography, 2011-2018 ($Million)
  • Table 14: Global Other Preparations Market For Animal Antimicrobials And Antibiotics, By Geography, 2011-2018 ($Million)
  • Table 15: Global Animal Antimicrobials And Antibiotics Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 16: Global Antimicrobials And Antibiotics Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 17: Global Food-Producing Animals Antimicrobials And Antibiotics Market, By Country, 2011-2018 ($Million)
  • Table 18: Global Animal Antimicrobials And Antibiotics Market For Cattle, By Country, 2011-2018 ($Million)
  • Table 19: Global Market For Pigs, By Country, 2011-2018 ($Million)
  • Table 20: Global Market For Poultry, By Country, 2011-2018 ($Million)
  • Table 21: Global Market For Sheep And Goats, By Country, 2011-2018 ($Million)
  • Table 22: Global Companion Animal Antimicrobials And Antibiotics Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 23: Global Companion Animal Antimicrobials And Antibiotics Market, By Country, 2011-2018 ($Million)
  • Table 24: Global Market For Dogs, By Country, 2011-2018 ($Million)
  • Table 25: Global Market For Cats, By Country, 2011-2018 ($Million)
  • Table 26: Global Market For Horses, By Country, 2011-2018 ($Million)
  • Table 27: Global Market For Other Animals (Fishes And Rabbits) Market, By Country, 2011-2018 ($Million)
  • Table 28: Animal Antimicrobials And Antibiotics Market, By Geography, 2011-2018 ($Million)
  • Table 29: North America: Veterinary Antimicrobials And Antibiotics Market, By Country, 2011-2018 ($Million)
  • Table 30: North America: Market, By Product, 2011-2018 ($Million)
  • Table 31: North America: Market, By Mode Of Delivery, 2011-2018 ($Million)
  • Table 32: North America: Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 33: North America: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 34: North America: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 35: U.S.: Veterinary Antimicrobials And Antibiotics Market, By Product, 2011-2018 ($Million)
  • Table 36: U.S.: Market, By Mode Of Delivery, 2011-2018 ($Million)
  • Table 37: U.S.: Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 38: U.S.: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 39: U.S.: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 40: Canada: Veterinary Antimicrobials And Antibiotics Market, By Product, 2011-2018 ($Million)
  • Table 41: Canada: Market, By Mode Of Delivery, 2011-2018 ($Million)
  • Table 42: Canada: Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 43: Canada: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 44: Canada: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 45: Europe: Veterinary Antimicrobials And Antibiotics Market, By Country, 2011-2018 ($Million)
  • Table 46: Europe: Market, By Product, 2011-2018 ($Million)
  • Table 47: Europe: Market, By Mode Of Delivery, 2011-2018 ($Million)
  • Table 48: Europe: Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 49: Europe: Market For Food Producing Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 50: Europe: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 51: U.K.: Animal Antimicrobials And Antibiotics Market, By Product, 2011-2018 ($Million)
  • Table 52: U.K.: Market, By Mode Of Delivery, 2011-2018 ($Million)
  • Table 53: U.K.: Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 54: U.K.: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 55: U.K.: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 56: Germany: Animal Antimicrobials And Antibiotics Market, By Product, 2011-2018 ($Million)
  • Table 57: Germany: Market, By Mode Of Delivery, 2011-2018 ($Million)
  • Table 58: Germany: Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 59: Germany: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 60: Germany: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 61: France: Animal Antimicrobials And Antibiotics Market, By Product, 2011-2018 ($Million)
  • Table 62: France: Market, By Mode Of Delivery, 2011-2018 ($Million)
  • Table 63: France: Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 64: France: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 65: France: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 66: Italy: Animal Antimicrobials And Antibiotics Market, By Product, 2011-2018 ($Million)
  • Table 67: Italy: Market, By Mode Of Delivery, 2011-2018 ($Million)
  • Table 68: Italy: Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 69: Italy: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 70: Italy: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 71: Spain: Animal Antimicrobials And Antibiotics Market, By Product, 2011-2018 ($Million)
  • Table 72: Spain: Market, By Mode Of Delivery, 2011-2018 ($Million)
  • Table 73: Spain: Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 74: Spain: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 75: Spain: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 76: Roe: Animal Antimicrobials And Antibiotics Market, By Product, 2011-2018 ($Million)
  • Table 77: Roe: Market, By Mode Of Delivery, 2011-2018 ($Million)
  • Table 78: Roe: Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 79: Roe: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 80: Roe: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 81: Apac: Animal Antimicrobials And Antibiotics Market, By Country, 2011-2018 ($Million)
  • Table 82: Apac: Market, By Product, 2011-2018 ($Million)
  • Table 83: Apac: Market, By Mode Of Delivery , 2011-2018 ($Million)
  • Table 84: Apac: Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 85: Apac: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 86: Apac: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 87: Japan: Animal Antimicrobials And Antibiotics Market, By Product, 2011-2018 ($Million)
  • Table 88: Japan: Market, By Mode Of Delivery, 2011-2018 ($Million)
  • Table 89: Japan: Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 90: Japan: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 91: Japan: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 92: China: Animal Antimicrobials And Antibiotics Market, By Product, 2011-2018 ($Million)
  • Table 93: China: Market, By Mode Of Delivery, 2011-2018 ($Million)
  • Table 94: China: Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 95: China: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 96: China : Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 97: India: Animal Antimicrobials And Antibiotics Market, By Product, 2011-2018 ($Million)
  • Table 98: India: Market, By Mode Of Delivery, 2011-2018 ($Million)
  • Table 99: India: Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 100: India: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 101: India: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 102: Rest Of Apac: Animal Antimicrobials And Antibiotics Market, By Products, 2011-2018 ($Million)
  • Table 103: Rest Of Apac: Market, By Mode Of Delivery, 2011-2018 ($Million)
  • Table 104: Rest Of Apac: Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 105: Rest Of Apac: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 106: Rest Of Apac: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 107: Row: Veterinary Antimicrobials And Antibiotics Market, By Geography, 2011-2018 ($Million)
  • Table 108: Row: Market, By Product, 2011-2018 ($Million)
  • Table 109: Row: Market, By Mode Of Delivery, 2011-2018 ($Million)
  • Table 110: Row: Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 111: Row: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 112: Row: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 113: Latin America: Veterinary Antimicrobials And Antibiotics Market, By Product, 2011-2018 ($Million)
  • Table 114: Latin America: Market, By Mode Of Delivery, 2011-2018 ($Million)
  • Table 115: Latin America: Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 116: Latin America: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million))
  • Table 117: Latin America: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 118: Middle East And Africa: Veterinary Antimicrobials And Antibiotics Market, By Product, 2011-2018 ($Million)
  • Table 119: Middle East And Africa: Market, By Mode Of Delivery, 2011-2018 ($Million)
  • Table 120: Middle East And Africa: Market, By Type Of Animal, 2011-2018 ($Million)
  • Table 121: Middle East And Africa: Market For Food-Producing Animals, By Type Of Animal, 2011-2018 ($Million) ($Million)
  • Table 122: Middle East And Africa: Market For Companion Animals, By Type Of Animal, 2011-2018 ($Million)
  • Table 123: Growth Strategy Matrix, 2010-2014
  • Table 124: Mergers And Acquisitions, 2010-2014
  • Table 125: New Product Launches, 2010-2014
  • Table 126: Agreements, Collaborations, And Partnerships, 2010-2014
  • Table 127: Expansions, 2010-2014
  • Table 128: Other Developments, 2010-2014

List Of Figures

  • Figure 1: Research Methodology
  • Figure 2: Market Size Estimation Methodology
  • Figure 3: Data Triangulation Methodology
  • Figure 1: Global Animal Antimicrobials And Antibiotics Market, By Product Type ($Million)
  • Figure 2: Global Animal Antimicrobials And Antibiotics Market, By Animal Type ($Million)
  • Figure 3: High-Growth Markets, 2013
  • Figure 4: Projected Global Consumption Of Meat And Dairy Products, 2010-2050
  • Figure 5: Global Antimicrobials And Antibiotics Market Revenue Trend, 2011-2018 ($Million)
  • Figure 6: Market Segementation
  • Figure 7 : arket Share Analysis, 2013 55
  • Figure 8 : ey Growth Strategies Of Veterinary Antimicrobial And Antibiotics Market, 2010-2014
  • Figure 9 : oetis, Inc.: Total Business Revenue ($Million), 2011-2013
  • Figure 10: Zoetis, Inc.: Revenue, By Business, 2013
  • Figure 11: Zoetis, Inc.: Business Revenue, By Geography, 2013
  • Figure 12: Merck And Co., Inc.: Total Business Revenue($Million), 2011-2013
  • Figure 13: Merck And Co., Inc.: Revenue, By Business, 2013
  • Figure 14: Merck And Co., Inc.: Business Revenue, By Geography, 2013 212
  • Figure 15: Bayer Ag: Revenue Segmentation, 2013
  • Figure 16: Bayer Consumer Health: Total Business Revenue ($Million),2011-2013
  • Figure 17: Bayer Consumer Health: Revenue, By Business, 2013
  • Figure 18: Bayer Consumer Health: Business Revenue, By Geography, 2013
  • Figure 19: Virbac Sa: Business Revenue ($Million), 2010-2012
  • Figure 20: Virbac Sa: Revenue, By Business, 2012
  • Figure 21: Virbac Sa: Business Revenue, By Geography, 2012
  • Figure 22: Eli Lilly And Company: Elanco Animal Health Business Revenue ($Million), 2011-2013
  • Figure 23: Eli Lilly And Company: Total Revenue, By Business, 2013
  • Figure 24: Eli Lilly And Company:Elanco Animal Healthbusiness Revenue, By Geography, 2013
  • Figure 25: Boehringer Ingelheim: Revenue Segmentation, 2012
  • Figure 26: Boehringer Ingelheim: Total Business Revenue ($Million), 2010-2012
  • Figure 27: Boehringer Ingelheim: Revenue, By Business, 2012
  • Figure 28: Boehringer Ingelheim: Animal Health Business Revenue, By Geography, 2012
  • Figure 29: Sanofi: Revenue Segmentation, 2013
  • Figure 30: Merial: Total Business Revenue ($Million), 2011-2013
  • Figure 31: Merial: Revenue, By Business, 2013
  • Figure 32: Merial: Business Revenue, By Geography, 2013
  • Figure 33: Novartis Ag: Revenue Segmentation, 2013
  • Figure 34: Novartis Consumer Health: Total Business Revenue($Million), 2011-2013
  • Figure 35: Novartis Ag: Revenue, By Business, 2013
  • Figure 36: Novartis Consumer Health: Business Revenue, By Geography, 2013
  • Figure 37: Ceva Sante Animale: Total Business Revenue ($Million), 2010-2012
  • Figure 38: Cevasante Animale: Business Revenue, By Geography, 2012
  • Figure 39: Vetoquinol: Business Revenue ($Million), 2011-2013
  • Figure 40: Vetoquinol: Business Revenue, By Geography, 2013
Back to Top